Matthew O’Connor - Concepedia

Author

Matthew O’Connor

Also Known As

M J O'Connor, M O'Connor, M O`Connor, M Oconnor, M O’connor, M. O'Connor, M. O’Connor, Margaret H. O’Connor, Matthew J. O'Connor, Matthew J. O’Connor

Publications

1.2K

Citations

H-Index

Concepts

All Affiliations

Auckland City Hospital Guy's and St Thomas' NHS Foundation Trust Harvard University King's College Hospital University of Virginia Health System

About

Matthew O’Connor is an author at Auckland City Hospital specializing in medicine, pharmacology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	12	510
2	Health Sciences	4	4	78
3	Cell Biology	4	4	313
4	Biochemistry	1	1	25
5	Cellular Physiology	1	1	58

Matthew O’Connor

Publications

Citations

H-Index

Page 1

	Year	Citations
Discovery of OSI-906: A Selective and Orally Efficacious Dual Inhibitor of the IGF-1 Receptor and Insulin Receptor Mark J. Mulvihill, Andrew Cooke, Maryland Rosenfeld-Franklin, Future Medicinal Chemistry	2009	307
A novel, potent, and selective insulin-like growth factor-I receptor kinase inhibitor blocks insulin-like growth factor-I receptor signaling <i>in vitro</i> and inhibits insulin-like growth factor-I receptor–dependent tumor growth <i>in vivo</i> Qunsheng Ji, Mark J. Mulvihill, Maryland Rosenfeld-Franklin, Molecular Cancer Therapeutics Igf-ii ExpressionSignal TransductionGrowth HormoneHuman Insulin ReceptorTumor Growth	2007	147
OSI-930: A Novel Selective Inhibitor of Kit and Kinase Insert Domain Receptor Tyrosine Kinases with Antitumor Activity in Mouse Xenograft Models Andrew J. Garton, Andrew P. Crew, Maryland Franklin, Cancer Research Mouse Xenograft ModelsAntitumor ActivityChemoprevention StrategySimilar PotencyCancer Biology	2006	80
Optimizing Cerebral Autoregulation May Decrease Neonatal Regional Hypoxic-Ischemic Brain Injury Jennifer K. Lee, Andrea Poretti, Jamie Perin, Developmental Neuroscience	2016	75
Inducible expression of TGFβ, Snail and Zeb1 recapitulates EMT in vitro and in vivo in a NSCLC model Gretchen Argast, Joseph S. Krueger, Stuart Thomson, Clinical & Experimental Metastasis Nsclc ModelDevelopmental BiologySignal TransductionInducible ExpressionCell Signaling	2011	58
Conduction System Pacing Versus Conventional Cardiac Resynchronization Therapy in Congenital Heart Disease Jeremy P. Moore, Natasja M.S. de Groot, Matthew O’Connor, JACC. Clinical electrophysiology Heart FailureCardiac AnaesthesiaDevice TherapyPediatric Heart DiseaseAdult Congenital Heart Disease	2022	42
1,3-Disubstituted-imidazo[1,5-a]pyrazines as insulin-like growth-factor-I receptor (IGF-IR) inhibitors Mark J. Mulvihill, Qunsheng Ji, Doug Werner, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryMedicineMechanism Of ActionPharmacotherapyDrug Development	2006	32
Incomplete and Atypical Kawasaki Disease in a Young Infant: Severe, Recalcitrant Disease Responsive to Infliximab Matthew O’Connor, Frank T. Saulsbury Clinical Pediatrics ThrombosisRheumatologyTranslational MedicineVasculitisAutoimmune Disease	2007	32
Cooperative Signaling between Oncostatin M, Hepatocyte Growth Factor and Transforming Growth Factor-β Enhances Epithelial to Mesenchymal Transition in Lung and Pancreatic Tumor Models Gretchen Argast, Peter Mercado, Iain J. Mulford, Cells Tissues Organs PathologyCell ProliferationEmt StatesCancer BiologyTumor Biology	2010	28
Caldesmon and heat shock protein 20 phosphorylation in nitroglycerin- and magnesium-induced relaxation of swine carotid artery Christopher M. Rembold, Matthew O’Connor Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease Magnesium-induced RelaxationBiochemistryHeat ShockMedicinePhysiology	2000	25

Page 1